TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial.

Joyce F Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.